Science ❯ Medical Research ❯ Clinical Trials

Oncology

mRNA Technology Survival Rates mRNA Treatments AI Technology Glioblastoma Research Precision Medicine Preventive Medicine Cell Therapy Phase 1/2 Trials for HLD-0915 Non-Small Cell Lung Cancer Breast Cancer Studies Drug Development Solid Tumors FLASH Proton Therapy

Penn Launches Phase I Trial of ConformalFLASH Proton Therapy

Researchers will test if ultra-fast, sub‑second proton doses shorten treatment to days with less harm to healthy tissue.

Tempus Shares Reprice After Merck–Moderna Phase 3 Win Boosts Value of Sequencing Business

Iovance Posts Record Q2 Revenue on Strong Amtagvi Sales

Large Observational Studies Link GLP‑1 Drugs to Lower Cancer Rates and Slower Progression

Moderna Beats Q1 Forecast as Overseas COVID Shot Sales Rebound

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline